Department of Biochemistry, McGill University, Montréal, QC, Canada H3G 1Y6.
Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11824-9. doi: 10.1073/pnas.1205377109. Epub 2012 Jul 2.
Although glycopeptide antibiotics (GPAs), including vancomycin and teicoplanin, represent the most important class of anti-infective agents in the treatment of serious gram-positive bacterial infections, their usefulness is threatened by the emergence of resistant strains. GPAs are complex natural products consisting of a heptapeptide skeleton assembled via nonribosomal peptide synthesis and constrained through multiple crosslinks, with diversity resulting from enzymatic modifications by a variety of tailoring enzymes, which can be used to produce GPA analogues that could overcome antibiotic resistance. GPA-modifying sulfotransferases are promising tools for generating the unique derivatives. Despite significant sequence and structural similarities, these sulfotransferases modify distinct side chains on the GPA scaffold. To provide insight into the spatial diversity of modifications, we have determined the crystal structure of the ternary complex of bacterial sulfotransferase StaL with the cofactor product 3'-phosphoadenosine 5'-phosphate and desulfo-A47934 aglycone substrate. Desulfo-A47934 binds with the hydroxyl group on the 4-hydroxyphenylglycine in residue 1 directed toward the 3'-phosphoadenosine 5'-phosphate and hydrogen-bonded to the catalytic His67. Homodimeric StaL can accommodate GPA substrate in only one of the two active sites because of potential steric clashes. Importantly, the aglycone substrate demonstrates a flattened conformation, in contrast to the cup-shaped structures observed previously. Analysis of the conformations of this scaffold showed that despite the apparent rigidity due to crosslinking between the side chains, the aglycone scaffold displays substantial flexibility, important for enzymatic modifications by the GPA-tailoring enzymes. We also discuss the potential of using the current structural information in generating unique GPA derivatives.
虽然糖肽类抗生素(GPAs),包括万古霉素和替考拉宁,是治疗严重革兰氏阳性细菌感染的最重要的一类抗感染药物,但它们的用途受到耐药菌株出现的威胁。GPAs 是复杂的天然产物,由通过非核糖体肽合成组装的七肽骨架组成,并通过多个交联约束,其多样性来自各种修饰酶的酶促修饰,这些酶可用于产生可克服抗生素耐药性的 GPA 类似物。GPA 修饰硫酸转移酶是产生独特衍生物的有前途的工具。尽管存在显著的序列和结构相似性,但这些硫酸转移酶修饰 GPA 支架上不同的侧链。为了深入了解修饰的空间多样性,我们已经确定了细菌硫酸转移酶 StaL 与辅因子产物 3'-磷酸腺苷 5'-磷酸和去磺基-A47934 糖苷配基底物的三元复合物的晶体结构。去磺基-A47934 与残基 1 中 4-羟基苯甘氨酸上的羟基结合,朝向 3'-磷酸腺苷 5'-磷酸,并与催化 His67 形成氢键。由于潜在的空间位阻,同源二聚体 StaL 只能在两个活性位点中的一个容纳 GPA 底物。重要的是,糖苷配基底物表现出扁平构象,与之前观察到的杯状结构形成对比。对该支架构象的分析表明,尽管由于侧链之间的交联导致明显的刚性,但糖苷配基支架显示出很大的灵活性,这对于 GPA 修饰酶的酶促修饰很重要。我们还讨论了利用当前结构信息生成独特 GPA 衍生物的潜力。